Effect of Helicobacter pylori on delay in ulcer healing induced by aspirin in rats

European Journal of Pharmacology

Volumn 451, Issue 2, 2002, Pages 191-202

  Konturek, Peter C ^a   Brzozowski, Tomasz ^b   Kwiecień, Slawomir ^b   Drozdowicz, Danuta ^b   Harsch, Igor A ^a   Meixner, Holger ^a   Stachura, Jerzy ^b   Hahn, Eckhart G ^a   Konturek, Stanislaw J ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Aspirin; Cyclooxygenase; Gastric blood flow; Gastric secretion; Growth factor; Helicobacter pylori; Ulcer healing

Indexed keywords

ACETIC ACID; ACETYLSALICYLIC ACID; BACTERIAL DNA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GASTRIN; MESSENGER RNA; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CONTROLLED STUDY; DNA DETERMINATION; DRUG ANTAGONISM; DRUG EFFECT; GASTRIN BLOOD LEVEL; GENE EXPRESSION REGULATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; STOMACH ACID SECRETION; STOMACH BLOOD FLOW; STOMACH MUCOSA; STOMACH ULCER; ULCER HEALING;

ANIMALS; ASPIRIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GASTRIC ACID; GENE EXPRESSION; HELICOBACTER PYLORI; ISOENZYMES; MALE; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; RNA, MESSENGER; STOMACH ULCER; WOUND HEALING;

EID: 0037072526     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02250-1     Document Type: Article

References (37)

1. 2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon. Cancer Epidemiol. Biomark. Prev. 8:1999;311-315.
2. Bianchi Porro G., Parente F., Imbesi V., Montrone F., Caruso I. Role of Helicobacter in ulcer healing and recurrence of gastric and duodenal ulcers in long term NSAID users; response to omeprazole dual therapy. Gut. 39:1999;22-26.
3. Brzozowski T., Konturek P.C., Konturek S.J., Ernst H., Stachura J., Hahn E.G. Gastric adaptation to injury by repeated doses of aspirin strengthens mucosal defense against subsequent exposure to various strong irritants in rats. Gut. 37:1995;749-757.
4. Brzozowski T., Konturek P.C., Konturek J., Ernst H., Sliwowski Z., Hahn E.G. Mucosal irritation, adaptive cytoprotection and adaptation to topical ammonia in the rat stomach. Scand. J. Gastroenterol. 31:1996;837-846.
5. Brzozowski T., Konturek P.C., Konturek S.J., Karczewska E., Pajdo R., Stachura J., Ghiara P., Hahn E.G. Gastric secretion and ulcer healing in mouse stomach infected with cytotoxin expressing strain of Helicobacter pylori. J. Physiol. Pharmacol. 49:1998;387-403.
6. Brzozowski T., Konturek P.C., Konturek S.J., Schuppan D., Drozdowicz D., Kwiecien S., Majka J., Nakamura T., Hahn E.G. Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and cyclooxygenase-2. Digestion. 64:2001;15-29.
7. Chan F.K.L. Helicobacter pylori, NSAIDs and gastrointestinal hemorrhage. Eur. J. Gastroenterol. Hepatol. l4:2002;1-3.
8. Chan F.K.L., Sung J.J., Chung S.C., To K.F., Yung M.Y., Leung V.K., Lee Y.T., Chan C.S., Li E.K., Woo J. Randomized trial of eradication of H. pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet. 350:1997;975-979.
9. Chan F.K., Sung J.J., Suen R., Lee Y.T., Wu J.C., Leung W.K., Chan H.L., Lai A.C., Lau J.Y., Ng E.K., Chung S.C. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study. Aliment. Pharmacol. Ther. 12:1998;1201-1205.
10. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
11. Coffey R.J., Romano M., Goldenring J. Roles for transforming growth factor-α in the stomach. J. Clin. Gastroenterol. 21(Suppl. 1):1995;S36-S39.
12. Davies N.M., Sharkey K.A., Asfaha S., MacNaughton W.K., Wallace J.L. Aspirin causes rapid up-regulation of cyclooxygenase-2 expression in the stomach of the rats. Aliment. Pharmacol. Ther. 11:1997;1101-1108.
13. Dixon M.F., Genta R.M., Yardley J.H., Correa P. Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20:1996;1161-1181.
14. Drazek E.S., Dubois A., Holmes R.K. Characterization and presumptive identification of Helicobacter pylori isolates from rhesus monkeys. J. Clin. Microbiol. 32:1994;1799-1804.
15. Fendrick A.M., Scheiman J.M. Helicobacter pylori and NSAID gastropathy: an ambiguous association. Curr. Rheumatol. Rep. 1. 3(2):2001;107-111.
16. Hawkey C.J., Tulassay Z., Szczepanski L., van Rensburg C.J., Filipowicz-Sosnowska A., Lanas A., Wason C.M., Peacock R.A., Gillon K.R. Randomized controlled trial of Helicobacter pylori eradication in patients on nonsteroidal anti-inflammatory drugs: the HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. Lancet. 352:1998;1016-1021.
17. Hirose H., Takeuchi K., Okabe S. Effect of indomethacin on gastric mucosal blood flow around acetic acid-induced gastric ulcers in rats. Gastroenterology. 100:1991;1259-1265.
18. Huang J.-Q., Sridhar S., Hunt R. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic ulcer disease: a meta-analysis. Lancet. 359:2002;14-20.
19. Konturek P.C., Brzozowski T., Konturek S.J., Ernst H., Drozdowicz D., Pajdo R. Expression of epidermal growth factor and transforming growth factor alpha during ulcer healing. Scand. J. Gastroenterol. 32:1997;6-15.
20. Konturek J.W., Dembinski A., Konturek S.J., Stachura J., Domschke W. Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. Gastroenterology. 114:1998;245-255.
21. Konturek P.C., Brzozowski T., Konturek S.J., Taut A., Sliwowski Z., Stachura J., Hahn E.G. Activation of genes for growth factors and cyclooxygenase in rat gastric mucosa during recovery from stress damage. Eur. J. Pharmacol. 342:1998;55-65.
22. Konturek P.Ch., Brzozowski T., Konturek S.J., Stachura J., Karczewska E., Pajdo R., Ghiara P., Hahn E.G. Mouse model of Helicobacter pylori infection: studies of gastric function and ulcer healing. Aliment. Pharmacol. Ther. 13:1999;333-346.
23. Konturek S.J., Konturek P.C., Plonka A., Duda A., Sito E., Zuchowicz M., Hahn E.G. Implication of gastrin in cyclooxygenase-2 expression in Helicobacter pylori infected gastric ulceration. Prostaglandins Other Lipid Mediat. 66:2001;39-51.
24. Li H., Mellgard B., Helander H. Inoculation of VacA- and CagA-Helicobacter pylori delays gastric ulcer healing in rat. Scand. J. Gastroenterol. 32:1997;439-444.
25. Li H., Kalies I., Mellegard B., Helander H.F. A rat model of chronic Helicobacter infection. Studies on epithelial cell turnover and gastric ulcer healing. Scand. J. Gastroenterol. 33:1998;370-378.
26. Loeb D.S., Talley N.J., Alquist D.A., Carpenter H.A., Zinsmeister A.R. Long term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology. 102:1992;1899-1905.
27. Neufeld G., Tzafra C., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:1999;9-22.
28. Okabe S., Pfeiffer C.J., Roth J.L.A. A method for experimental, penetrating gastric and duodenal ulcers in rats. Am. J. Dig. Dis. 16:1971;277-284.
29. Penney A.G., Andrews F.J., O B'rien P.E. Effects of misoprostol on delayed ulcer healing induced by aspirin. Dig. Dis. Sci. 39:1994;934-939.
30. Szabo S., Vincze A. Growth factors in ulcer healing: lessons from recent studies. J. Physiol. (Paris). 94(2):2000;77-81.
31. Takahashi M., Ota S., Hata Y., Mikami Y., Azuma N., Nakamura T., Terano A., Omata M. Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach. J. Clin. Invest. 98:1996;2604-2611.
32. Takahashi M., Kawabe T., Ogura K., Maeda S., Mikami Y., Kaneko N., Terano A., Omata M. Expression of vascular endothelial growth factor at the human gastric margin and in cultured gastric fibroblasts: a new angiogenic factor for gastric ulcer healing. Biochem. Biophys. Res. Commun. 234:1997;493-498.
33. Takahashi M., Maeda S., Ogura K., Terano A., Omata M. The possible role of vascular endothelial growth factor (VEGF) in gastric ulcer healing: effect of sofalcone on VEGF release in vitro. J. Clin. Gastroenterol. 27(Suppl. 1):1998;S178-S182.
34. Tarnawski A. Cellular mechanism of gastric ulcer healing. Domschke W., Konturek S.J. The Stomach. 1993;177-192 Springer-Verlag, Berlin.
35. Tytgat G.N.J. Ulcers and gastritis. Endoscopy. 32:2000;108-117.
36. Wallace J.L. Cooperative modulation of gastrointestinal mucosal defense by prostaglandins and nitric oxide. Clin. Invest. Med. 19:1996;346-351.
37. Wang J.Y., Yamasaki S., Takeuchi K., Okabe S. Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology. 96:1989;393-402.